Order Article Reprints

Celesia A, Notaro A, Franzò M, Lauricella M, D’Anneo A, Carlisi D, Giuliano M, Emanuele S. The Histone Deacetylase Inhibitor ITF2357 (Givinostat) Targets Oncogenic BRAF in Melanoma Cells and Promotes a Switch from Pro-Survival Autophagy to Apoptosis. Biomedicines. 2022; 10(8):1994. https://doi.org/10.3390/biomedicines10081994

Celesia, Adriana, Antonietta Notaro, Marzia Franzò, Marianna Lauricella, Antonella D’Anneo, Daniela Carlisi, Michela Giuliano, and Sonia Emanuele. 2022. "The Histone Deacetylase Inhibitor ITF2357 (Givinostat) Targets Oncogenic BRAF in Melanoma Cells and Promotes a Switch from Pro-Survival Autophagy to Apoptosis" Biomedicines 10, no. 8: 1994. https://doi.org/10.3390/biomedicines10081994

Celesia, A., Notaro, A., Franzò, M., Lauricella, M., D’Anneo, A., Carlisi, D., Giuliano, M., & Emanuele, S. (2022). The Histone Deacetylase Inhibitor ITF2357 (Givinostat) Targets Oncogenic BRAF in Melanoma Cells and Promotes a Switch from Pro-Survival Autophagy to Apoptosis. Biomedicines, 10(8), 1994. https://doi.org/10.3390/biomedicines10081994